ACOR Financial Facts

Interest and amortization of debt discount expense: -286K
Cost of sales: 18.38M
See Full Income Statement

Put/call liability: 147K
Non-current portion of revenue interest liability: 493K
See Full Balance Sheet

Acorda Therapeutics, Inc. (ACOR) Earnings

  |   Expand Research on ACOR
Next EPS Date 5/5/14 *Est. EPS Growth Rate +33.3% *Last Qtr.
Average EPS % Beat Rate +100.4% Revenue Growth Rate +13.6% *Last Qtr.
Average % Move 1-Wk after EPS -1.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
11/4/11 Q311 $0.40$0.73 -$0.33$93.03M$90.78M N/A +69.3% Details
10/31/13 Q313 $0.36$0.13 +$0.23$84.92M$90.01M N/A +8.2% Details
2/13/14 Q413 $0.32$0.18 +$0.14$92.59M$89.96M N/A +11.8% Details
8/1/13 Q213 $0.25$0.09 +$0.16$87.05M$82.57M N/A -8.8% Details
5/2/13 Q113 $0.09$0.13 -$0.04$62.3M$80.71M N/A -9.5% Details
2/13/13 Q412 $0.24$0.15 +$0.09$81.47M$78.9M N/A +17.2% Details
10/31/12 Q312 $0.38$0.10 +$0.28$77.44M$75.2M N/A +54% Details
7/31/12 Q212 $0.27$0.12 +$0.15$75.66M$72.55M N/A +39.9% Details